Navigation Links
Medical International Technology Inc. "MIT" announces a minimum of 6 million dollars exclusive agreement for a period of 5 years with a Malaysian Distributor for its Med-Jet(R) Needle-Free Jet-Injector
Date:4/16/2009

DENVER, CO, April 16 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH. PK) (http://www.mitcanada.ca http://www.mitinvest.ca), is pleased to announce that its subsidiary Medical International Technologies (MIT Canada) Inc. has signed a minimum of six (6) million dollars exclusive "OEM" (Original Equipment Manufacturer) agreement for a period of 5 years with a Malaysian distributor for its Needle-Free Jet-Injector, models Med-Jet(R) MBX and Med-Jet(R)-H-III to be used in cosmetics, plastic surgeries, and medical applications, in many countries around the world. MIT is also in discussion with the same distributor for a new product that "MIT" will introduce within the next six months for the same niche market.

This "OEM" agreement will not prevent "MIT" from selling its own brand in the same market around the world; rather, it will help introduce "MIT's" unique technology to doctors worldwide.

"MIT" has already supplied the Malaysian distributor with over 80 units to cover his initial clients' demands in Malaysia, Philippines, and Vietnam. Moreover, they have participated in two of the largest exhibition for cosmetics and plastic surgeries in Asia, Hong Kong, and Shenzhen, China. The results were overwhelming and more orders were placed with an even larger order of one hundred units expected before the end of May 2009. "MIT's" Malaysian distributor is marketing the Med-Jet(R) all over Asia. His later focus will be placed on the European market.

"MIT's" technology is the outcome of more than twenty-eight years of research and development and the driving force behind the Med-Jet(R) product line for humans and the Agro-Jet(R) product line for animals.

"MIT" is consolidating its efforts, strengthening its team, reorganizing its marketing / sales departments and financial bases in anticipation of its future growth.

Medical International Technology Inc. is pleased to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet(R) and Agro-Jet(R) needle-free injection system.

Karim Menassa, President

On Behalf of the Board of Directors

About Medical International Technology, Inc. MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations.

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Medical International Technology Inc. takes no obligation to update or correct forward-looking statements.


'/>"/>
SOURCE MEDICAL INTERNATIONAL TECHNOLOGIES INC.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... Knoxville, Tenn. (PRWEB) , ... May 06, 2016 , ... The joy associated with Mother’s ... for their lives in neonatal intensive care units (NICUs) across the country. For the first ... are joining together to honor these women who spend their Mother’s Day beside a crib ...
(Date:5/6/2016)... ... 2016 , ... Bluvault ( Bluvault Inc. ) today announced ... clients of Coupa ( Coupa Software ) and other Cloud software, powered by ... component in the suite of innovative implementation services offered by Bluvault. , "Our ...
(Date:5/6/2016)... , ... May 06, 2016 , ... Online HR/benefits platforms ... are changing the game for traditional brokers and health plans. “ The Rapid Emergence ... 17 webinar from Atlantic Information Services, Inc. (AIS), will offer an accurate picture of ...
(Date:5/6/2016)... ... ... The International Yoga Teacher Training schoo l will be returning ... the town famous for its sunsets, Oia. This all inclusive yoga training retreat will ... amazing experience in Greece, we just can’t stay away” says Co-Founder Carri Uranga “The ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... 2013 arrival of Sovaldi, which made headlines mostly for its cost despite its ... policy and moral questions surrounding the drug—part of a class called direct-acting antivirals ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... -- Replikins Ltd. today reported initial promising results in animal trials of its Zika vaccine ... ... ... ... on Pubmed. The analysis identified the highest gene Replikin Counts in Zika history back ...
(Date:5/5/2016)... ORANGE COUNTY, Calif. , May 5, 2016 ... for nearly a decade due to concerns that ... advances in the approach to imaging, as well ... in a new era of medical peripherals that ... better care.   Ampronix  advanced medical imaging is a ...
(Date:5/5/2016)... May 5, 2016 ... the  "Europe Thalassaemia Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... Market and Competitive Landscape Highlights - 2016, ... Thalassaemia epidemiology, Thalassaemia market valuations and forecast, ...
Breaking Medicine Technology: